Inhibrx Biosciences Inc (INBX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current INBX market cap is 342.36M. The company's latest EPS is USD 116.5780 and P/E is 0.20.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 100k | 0 | 100k | 0 |
| Operating Income | -49.21M | -185.51M | -46.8M | -49.93M | -42.9M |
| Net Income | -49.27M | 1.83B | -43.86M | -47.87M | -43.31M |
| Year End December 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.32M | 1.63M | 200k |
| Operating Income | -115.32M | -152.75M | -331.45M |
| Net Income | -115.33M | -154.96M | 1.69B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Assets | 28.22M | 258.42M | 222.56M | 180.77M | 242.64M |
| Total Liabilities | 38.99M | 39.05M | 44.1M | 47.18M | 148.2M |
| Total Equity | -10.77M | 219.37M | 178.47M | 133.58M | 94.44M |
| Year End December 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.65M | 26M | 180.77M |
| Total Liabilities | 23.95M | 33.97M | 47.18M |
| Total Equity | -7.3M | -7.97M | 133.58M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Operating | -40.31M | -120.41M | -150.69M | -194.41M | -35.9M |
| Investing | -1.12M | -2.33M | -2.58M | -2.6M | -21k |
| Financing | 41.43M | 71.68M | 71.68M | 71.68M | 99.84M |
| Year End December 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -90.81M | -129.01M | -194.41M |
| Investing | -686k | -4.59M | -2.6M |
| Financing | 91.5M | 133.6M | 71.68M |
| Market Cap | 342.36M |
| Price to Earnings Ratio | 0.20 |
| Price to Sales Ratio | 1.71k |
| Price to Cash Ratio | 2.24 |
| Price to Book Ratio | 2.56 |
| Dividend Yield | - |
| Shares Outstanding | 14.48M |
| Average Volume (1 week) | 120.73k |
| Average Volume (1 Month) | 141.17k |
| 52 Week Change | 66.55% |
| 52 Week High | 23.9899 |
| 52 Week Low | 10.80 |
| Spread (Intraday) | 14.54 (60.58%) |
| Company Name | Inhibrx Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.inhibrx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
